158
Views
14
CrossRef citations to date
0
Altmetric
Original Article

Safety profile of silver sulfadiazine-bFGF-loaded hydrogel for partial thickness burn wounds

, , , , &
Pages 258-266 | Received 05 Jan 2018, Accepted 15 Feb 2018, Published online: 12 Mar 2018

References

  • Kumar PM, Ghosh A. Development and evaluation of silver sulfadiazine loaded microsponge based gel for partial thickness (second degree) burn wounds. Eur J Pharm Sci 2017;96:243–254.
  • Venkataraman M, Nagarsenker M. Silver sulfadiazine nanosystems for burn therapy. AAPS PharmSCiTech 2013;14:254–264.
  • Carr HS, Wlodkowski TJ, Rosenkranz HS. Silver sulfadiazine: in vitro antibacterial activity. Antimicrob Agents Chemother 1973;4:585–587.
  • Atiyeh BS, Costagliola M, Hayek SN, Dibo SA. Effect of silver on burn wound infection control and healing: review of the literature. Burns 2007;33:139–148.
  • Khorasani G, Hosseinimehr SJ, Azadbakht M, et al. Aloe versus silver sulfadiazine creams for second-degree burns: a randomized controlled study. Surg Today 2009;39:587–591.
  • Patino MG, Neiders ME, Andreana S, et al. Collagen as an implantable material in medicine and dentistry. J Oral Implantol 2002;28:220–225.
  • Doǧan AK, Gümüşderelioǧlu M, Aksöz E. Controlled release of EGF and bFGF from dextran hydrogels in vitro and in vivo. J Biomed Mater Res Part B Appl Biomater 2005;74:504–510.
  • Barrientos S, Stojadinovic O, Golinko MS, et al. Growth factors and cytokines in wound healing. Wound Repair Regen 2008;16:585–601.
  • Silva AK, Richard C, Bessodes M, et al. Growth factor delivery approaches in hydrogels. Biomacromolecules 2008;10:9–18.
  • OECD. 2002a. OECD guideline for testing of chemicals-acute dermal irritation, corrosion, revised version, guideline no. 404, adopted May 1981. Rome, Italy: OECD. Available from: https://ntp.niehs.nih.gov/iccvam/suppdocs/feddocs/oecd/oecdtg404.pdf [last accessed 1 Sept 2017].
  • Draize JH. The appraisal of chemicals in foods, drugs and cosmetics. Austin, TX: The Association of Food and Drug Officials of the United States; 1959, p. 46.
  • Banerjee S, Chattopadhyay P, Ghosh A, et al. Acute dermal irritation, sensitization, and acute toxicity studies of a transdermal patch for prophylaxis against (±) anatoxin-A poisoning. Int J Toxicol 2013;32:308–313.
  • OECD. 1992. OECD guideline for testing of chemicals-skin sensitization, guideline no. 406, adopted July, 1992. Rome, Italy: OECD. Avaialble from: https://ntp.niehs.nih.gov/iccvam/suppdocs/feddocs/oecd/oecdtg406.pdf [last accessed 1 Sept 2017].
  • OECD. 1987. OECD guideline for testing of chemicals-acute dermal toxicity, guideline no. 402, adopted february 1987. Rome, Italy: OECD. Available from: https://www.oecd.org/env/ehs/testing/2-TG%20402_draft_26%20Oct%202015.pdf [last accessed 9 Sept 2017].
  • OECD. 2012. OECD guideline for testing of chemicals-acute eye irritation/corrosion, corrosion, revised version, guideline no. 405, adopted October 2012. Rome, Italy: OECD. Available from: https://ntp.niehs.nih.gov/iccvam/suppdocs/feddocs/oecd/oecd-tg405-2012-508.pdf [last accessed 9 Sept 2017].
  • Lansdown AB. A pharmacological and toxicological profile of silver as an antimicrobial agent in medical devices. Adv Pharmacol Sci 2010;2010:910686.
  • Chaloupka K, Malam Y, Seifalian AM. Nanosilver as a new generation of nanoproduct in biomedical applications. Trends Biotechnol 2010;28:580–588.
  • Asha Rani PV, Low Kah Mun G, Hande MP, Valiyaveettil S. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano 2009;24:279–290.
  • Kim S, Choi JE, Choi J, et al. Oxidative stress-dependent toxicity of silver nanoparticles in human hepatoma cells. Toxicol in Vitro 2009;23:1076–1084.
  • Ahamed M, Karns M, Goodson M, et al. DNA damage response to different surface chemistry of silver nanoparticles in mammalian cells. Toxicol Appl Pharmacol 2008;233:404–410.
  • White R. Silver and nanoparticles of silver in wound dressings: a review of efficacy and safety. J Wound Care 2011;20:543–549.
  • Chen X, Schluesener HJ. Nanosilver: a nanoproduct in medical application. Toxicol Lett 2008;176:1–12.
  • Wijnhoven SW, Peijnenburg WJ, Herberts CA, et al. Nano-silver – a review of available data and knowledge gaps in human and environmental risk assessment. Nanotoxicology 2009;3:109–138.
  • Parwani L, Bhatnagar M, Bhatnagar A, et al. Evaluation of Moringa oleifera seed biopolymer-PVA composite hydrogel in wound healing dressing. Iran Polym J 2016;25:919–931.
  • Wang T, Zhu XK, Xue XT, Wu DY. Hydrogel sheets of chitosan, honey and gelatin as burn wound dressings. Carbohydr Polym 2012;88:75–83.
  • Farsi E, Esmailli K, Shafaei A, et al. Mutagenicity and preclinical safety assessment of the aqueous extract of Clinacanthus nutans leaves. Drug Chem Toxicol 2016;39:461–473.
  • Huang Y, Li X, Liao Z, et al. A randomized comparative trial between Acticoat and SD-Ag in the treatment of residual burn wounds, including safety analysis. Burns 2007;33:161–166.
  • Vlachou E, Chipp E, Shale E, et al. The safety of nanocrystalline silver dressings on burns: a study of systemic silver absorption. Burns 2007;33:979–85.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.